0001787306ARCUTIS BIOTHERAPEUTICS, INC.S-3S-3ASREX-FILING FEESN/AN/Axbrli:pureiso4217:USD00017873062026-02-252026-02-25000178730612026-02-252026-02-25000178730622026-02-252026-02-25000178730632026-02-252026-02-25000178730642026-02-252026-02-25000178730652026-02-252026-02-25000178730662026-02-252026-02-25
Calculation of Filing Fee Table
Form S-3
(Form Type)
Arcutis Biotherapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward |
| Security Type | | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial Effective Date |
Newly Registered Securities |
| Fees to Be Paid | Equity | 1 | Common Stock, par value $0.0001 per share | 457(r) | | | | $0.000138 | | | | | |
| Equity | 2 | Preferred Stock, par value $0.0001 per share | 457(r) | | | | $0.000138 | | | | | |
| Debt | 3 | Debt Securities | 457(r) | | | | $0.000138 | | | | | |
| Other | 4 | Warrants | 457(r) | | | | $0.000138 | | | | | |
| Other | 5 | Purchase Contracts | 457(r) | | | | $0.000138 | | | | | |
| Other | 6 | Units | 457(r) | | | | $0.000138 | | | | | |
| Fees Previously Paid | | | | | | | | | | | | | |
| Carry Forward Securities |
| Carry Forward Securities | | | | | | | | | | | | | |
Total Offering Amounts | | $— | | $— | | | | |
Total Fees Previously Paid | | | | $— | | | | |
Total Fee Offsets | | | | $— | | | | |
Net Fee Due | | | | $— | | | | |
Offering Note
(1)
1.a. An unspecified number of securities or aggregate principal amount, as applicable, is being registered as may from time to time be offered at unspecified prices and, in addition, an unspecified number of securities is being registered as may be issued from time to time upon exercise, settlement, exchange or conversion of securities offered or sold hereunder. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), this registration statement also covers any additional securities that may be offered or issued in connection with any stock split, stock dividend or pursuant to anti-dilution provisions of any of the securities. Separate consideration may or may not be received for securities that are issuable upon conversion, exercise or exchange of other securities.
1.b. Includes rights to acquire common stock or preferred stock under any shareholder rights plan then in effect, if applicable under the terms of any such plan.
1.c. In accordance with Rules 456(b) and 457(r) under the Securities Act, the registrant is deferring payment of the entire registration fee and will pay such fees subsequently in advance or on a “pay-as-you-go” basis.
(2)See notes 1.a., 1.b. and 1.c. above.
(3)See notes 1.a. and 1.c. above.
(4)See notes 1.a. and 1.c. above.
(5)See notes 1.a. and 1.c. above.
(6)See notes 1.a. and 1.c. above.